Literature DB >> 7594717

Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease.

D K Howe1, L D Sibley.   

Abstract

The population genetic structure of Toxoplasma gondii was determined by multilocus restriction fragment length polymorphism analysis at 6 loci in 106 independent isolates from humans and animals. Phylogenetic and statistical analyses indicated a highly unusual population structure consisting of 3 widespread clonal lineages. Extensively mixed genotypes were only apparent in 4 strains, which indicated that, while not separate species, sexual recombination between the 3 lineages is exceedingly rare in natural populations. T. gondii is a major cause of subclinical human infection and an important opportunistic pathogen that causes severe disease in immunocompromised patients. While strains from all 3 lineages were isolated from humans, the majority of human toxoplasmosis cases were associated with strains of a type II genotype. The correlation of specific clonal lineages with human toxoplasmosis has important implications for development of vaccines, drug treatments, and diagnostic protocols.

Entities:  

Mesh:

Year:  1995        PMID: 7594717     DOI: 10.1093/infdis/172.6.1561

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  358 in total

1.  Rapid identification of virulent type I strains of the protozoan pathogen Toxoplasma gondii by PCR-restriction fragment length polymorphism analysis at the B1 gene.

Authors:  M E Grigg; J C Boothroyd
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 2.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

3.  Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation.

Authors:  Y W Zhang; K Kim; Y F Ma; M Wittner; H B Tanowitz; L M Weiss
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

4.  Enzyme-linked immunosorbent assays using the recombinant dense granule antigens GRA6 and GRA1 of Toxoplasma gondii for detection of immunoglobulin G antibodies.

Authors:  L Lecordier; M P Fourmaux; C Mercier; E Dehecq; E Masy; M F Cesbron-Delauw
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

5.  Daughter cell assembly in the protozoan parasite Toxoplasma gondii.

Authors:  Ke Hu; Tara Mann; Boris Striepen; Con J M Beckers; David S Roos; John M Murray
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

6.  Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii.

Authors:  L David Sibley; Dana G Mordue; Chunlei Su; Paul M Robben; Dan K Howe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-01-29       Impact factor: 6.237

7.  Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database.

Authors:  Li Li; Brian P Brunk; Jessica C Kissinger; Deana Pape; Keliang Tang; Robert H Cole; John Martin; Todd Wylie; Mike Dante; Steven J Fogarty; Daniel K Howe; Paul Liberator; Carmen Diaz; Jennifer Anderson; Michael White; Maria E Jerome; Emily A Johnson; Jay A Radke; Christian J Stoeckert; Robert H Waterston; Sandra W Clifton; David S Roos; L David Sibley
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

8.  Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana.

Authors:  B Carme; F Bissuel; D Ajzenberg; R Bouyne; C Aznar; M Demar; S Bichat; D Louvel; A M Bourbigot; C Peneau; P Neron; M L Dardé
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

9.  Differential gene expression in mice infected with distinct Toxoplasma strains.

Authors:  Rachel D Hill; Julia S Gouffon; Arnold M Saxton; Chunlei Su
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

10.  Toxoplasma GRA15 limits parasite growth in IFNγ-activated fibroblasts through TRAF ubiquitin ligases.

Authors:  Debanjan Mukhopadhyay; Lamba Omar Sangaré; Laurence Braun; Mohamed-Ali Hakimi; Jeroen Pj Saeij
Journal:  EMBO J       Date:  2020-04-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.